🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalMedical tourism for GLP-1 — anyone have experience? Page 5

Medical tourism for GLP-1 — anyone have experience?

ChrisMacros Sat, Apr 26, 2025 at 4:52 AM 36 replies 2,034 viewsPage 5 of 8
LondonLisa
Member
912
3,456
Mar 2024
London, UK
May 1, 2025 at 9:07 AM#21

One thing that is still open after Dr.DermMIA’s answer:

What did you change at the same time, and can you separate the two now?

38 13SaraMom3, Dr.MetabolicMD, RetaRick_CA and 35 others
Reply Quote Save Share Report
BiostatsBrad
Member
456
2,345
Jul 2024
Durham, NC
May 3, 2025 at 12:35 AM#22
marco_milano said:
Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third…

Pushing back on marco_milano here. This treats a plausible mechanism as a demonstrated one. Plausible is where you start looking, not where you stop.

37 12Dr.BariatricHTX, LindaRN_retired, tommy_boulder and 34 others
Reply Quote Save Share Report
MaxMetOK
Member
312
1,123
Dec 2024
Oklahoma
May 4, 2025 at 4:02 PM#23
marco_milano said:
Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third…

Correct, and worth adding that it is reversible. Nothing being described here is a one-way door, which changes how cautious it is reasonable to be.

36 11DoseLogDan, SleepFixSam, PurityPaulOR and 33 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
PeptideSynthNJ
Member
234
1,234
Aug 2024
Princeton, NJ
May 6, 2025 at 7:28 AM#24
marco_milano said:
Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third…

This answered a question I did not know how to ask. Sending this to two other people who asked me the same thing last week.

Last edited: May 6, 2025 at 11:28 AM
35 10MikeKY_noInsulin, Dr.RaviCardio, jennifer_SEA and 32 others
Reply Quote Save Share Report
chris_chi24
Member
389
1,678
Sep 2024
Chicago, IL
May 7, 2025 at 10:54 PM#25

From the other side of the consultation, briefly. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

34 9SleepFixSam, PurityPaulOR, MaxMetOK and 31 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register